News

Brooks Automation and Cleveland Clinic have opened a new 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus. The 22,000-square-foot ultra-cold and cryogenic storage facility will enhance researchers’ study to accelerate breakthroughs and optimize patient care.

New life sciences brand enables breakthroughs to market with a fully integrated portfolio for unparalleled sample exploration and management solutions

Brooks announces intention to separate into two independent publicly traded companies. The transaction is intended to be structured as a pro-rata distribution of shares to Brooks shareholders in a tax-efficient manner.

By integrating BioStore III with Cytiva’s Chronicle software, we are helping customers add the documented rigor around cold chain, inventory and handling which previously did not exist.

NCI, the nation’s leader in cancer research, chooses GENEWIZ to provide whole exome sequencing to new research projects at its Center for Cancer Genomics.

We are pleased to announce that Brooks Life Sciences has completed the acquisition of Trans-Hit Bio, a company with deep expertise in the biospecimen sourcing space.

Brooks' own Amy Liao, PhD – co-founder of GENEWIZ, A Brooks Life Sciences Company, and President of Brooks Life Sciences Services – receives the Wallace H. Coulter Healthcare Innovation Award from the Biomedical Engineering Society.

Ideal for Cell and Gene Therapy and COVID-19 research, BioStore IIIv provides improved thermal stability for stored materials, risk mitigation advantages and processes which are documented and repeatable.